K. Nakada et al., TL-201 SCINTIGRAPHY TO PREDICT THERAPEUTIC OUTCOME OF I-131 THERAPY OF METASTATIC THYROID-CARCINOMA, The Journal of nuclear medicine, 39(5), 1998, pp. 807-810
We studied the relationship between Tl-201 uptake and the efficacy of
radioiodine therapy in thyroid carcinoma. Methods: Forty-four patients
with metastases of well-differentiated thyroid carcinoma received Tl-
201 scintigraphy within the 2 mo before their initial I-131 therapy. P
atients were classified into two groups according to the tumor-to-back
ground (T/B) ratio on the late Tl-201 scan: high Tl-201 uptake (T/B gr
eater than or equal to 2.1) and low Tl-201 uptake (T/B < 2.1), The the
rapeutic outcome was judged by the percent reduction in the tumor diam
eter at 6 mo after the treatment. The treatment was defined as effecti
ve when the tumor showed more than 50% reduction in the tumor diameter
. The patients in whom radioiodine was ineffective were followed up to
determine if the tumor showed further growth. Results: Of the 44 pati
ents, 25 had high Tl-201 uptake and 19 had low Tl-201 uptake. The ther
apy was effective in 15 patients and was ineffective in 29, All the pa
tients in whom radioiodine was effective had low Tl-201 uptake. On the
other hand, 25 of 29 patients in whom radioiodine was ineffective had
high Tl-201 uptake. Eight patients, in whom radioiodine was ineffecti
ve despite good I-131 uptake, had high Tl-201 uptake. There were no si
gnificant differences in the positive predictive value and the negativ
e predictive value for effective treatment between Tl-201 scintigraphy
and therapeutic dose I-131 scintigraphy, Among the 25 patients in who
m radioiodine was ineffective and who had high Tl-201 uptake, the tumo
r diameter increased in 7 (28%). However, none of the tumors with low
Tl-201 uptake increased in size during the follow-up period. Conclusio
n: Thallium-201 scintigraphy has a high predictive value for the effic
acy of radioiodine therapy in metastatic thyroid carcinoma. Thus, it i
s helpful in determining the indication for radioiodine therapy and it
seems to be an adjunct to tracer dose I-131 scintigraphy.